106 related articles for article (PubMed ID: 2867247)
1. [Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease].
Kirichenko AA; Aslibekian IS; Ivanova LN; Zurabian KM
Klin Med (Mosk); 1985 Oct; 63(10):88-92. PubMed ID: 2867247
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of nadolol in coronary disease].
Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
[No Abstract] [Full Text] [Related]
3. [Use of nadolol in coronary disease].
Tkaczewski W; Goch JH; Dziekański S
Kardiol Pol; 1983; 26(3):215-9. PubMed ID: 6138456
[No Abstract] [Full Text] [Related]
4. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
[No Abstract] [Full Text] [Related]
5. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
Ostapiuk FE; Khvoĭnitskiĭ VA
Sov Med; 1984; (5):87-9. PubMed ID: 6147019
[No Abstract] [Full Text] [Related]
6. [Therapy of coronary disease with the beta-blocker betapressin].
Christandl B
Fortschr Med; 1981 Sep; 99(36):1473-6. PubMed ID: 6117510
[No Abstract] [Full Text] [Related]
7. Nadolol: a new beta-adrenoceptor antagonist.
Frishman WH
N Engl J Med; 1981 Sep; 305(12):678-82. PubMed ID: 6115316
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of nadolol in angina pectoris.
Cruz J; Conceicao JM; Coelho EM
Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
[No Abstract] [Full Text] [Related]
9. [Our experience on the clinical use of nadolol].
Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
[No Abstract] [Full Text] [Related]
10. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
Brügmann U; Blasini R
Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
[TBL] [Abstract][Full Text] [Related]
11. [Mitral valve prolapse. Evaluation of the efficacy of nadolol on the control of clinical symptoms and on the normalization of electrocardiographic tracings].
Bichuette HS
Arq Bras Cardiol; 1984 Dec; 43(6):449-56. PubMed ID: 6152676
[No Abstract] [Full Text] [Related]
12. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
[TBL] [Abstract][Full Text] [Related]
13. [Duration of effect and dose-response relationship of a new beta-sympatholytic agent in comparison with pindolol in patients with coronary heart disease].
Becker HJ; Matthäus EJ; Kaltenbach M
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1690-4. PubMed ID: 19897
[No Abstract] [Full Text] [Related]
14. [Effectiveness of the combined use of adrenergic beta receptor blockaders and long-acting nitrates in chronic ischemic heart disease].
Bragina GI
Klin Med (Mosk); 1981 Nov; 59(11):36-42. PubMed ID: 6119395
[No Abstract] [Full Text] [Related]
15. [Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
Korkushko OV; Shatilo VB; Butenko AG
Sov Med; 1989; (12):66-8. PubMed ID: 2483591
[No Abstract] [Full Text] [Related]
16. [Experiences with isosorbide dinitrate in combination with a beta receptor blockader (Bupranolol)].
Bernat AC; Riera de Barcia L
Med Monatsschr; 1976 Oct; 30(10):470-3. PubMed ID: 10516
[No Abstract] [Full Text] [Related]
17. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1982 Mar; 121(9):266-8. PubMed ID: 6121628
[No Abstract] [Full Text] [Related]
18. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
[TBL] [Abstract][Full Text] [Related]
19. Mediation of blood pressure by nadolol and alpha methyldopa.
Jenkins AC; Rosenthal J; Stumpe KO
Practitioner; 1981 Mar; 225(1353):405-9. PubMed ID: 6115378
[No Abstract] [Full Text] [Related]
20. [Comparative study of the anti-angina effectiveness of nadolol and propranolol].
Cremonesi A; Pagliarani PL; Guelfi P; Mattace R; Costa G; Bernardi G; Zacà F
Boll Soc Ital Cardiol; 1979; 24(7):741-5. PubMed ID: 45306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
